| Unique ID issued by UMIN | UMIN000055762 |
|---|---|
| Receipt number | R000063639 |
| Scientific Title | A Multicenter, Retrospective Study on the Risk of Non-Lung Cancer Death after Lobectomy and Sublobar Resection in Lung Cancer Patients |
| Date of disclosure of the study information | 2024/10/07 |
| Last modified on | 2024/10/07 16:05:47 |
A Multicenter, Retrospective Study on the Risk of Non-Lung Cancer Death after Lobectomy and Sublobar Resection in Lung Cancer Patients
Risk of Non-Lung Cancer Death and Surgical Procedure
A Multicenter, Retrospective Study on the Risk of Non-Lung Cancer Death after Lobectomy and Sublobar Resection in Lung Cancer Patients
Risk of Non-Lung Cancer Death and Surgical Procedure
| Japan |
Lung cancer
| Chest surgery | Adult |
Malignancy
NO
To determine whether there is an association between surgical procedure and the risk of death from other causes by retrospectively collecting data from multiple institutions on patients who have undergone curative resection for clinical stage I (7th edition) primary lung cancer and have not experienced recurrence of the primary disease.
Efficacy
Not applicable
Overall survival
Event-free survival by cause of death,overall survival by patient background factors
Observational
| 18 | years-old | <= |
| Not applicable |
Male and Female
1) Patients aged 18 years or older at the time of surgery who underwent complete resection for clinical stage IA or IB (TNM classification, 7th edition) primary lung cancer (or suspected) between January 1, 2013 and December 31, 2013.
2) Patients with a final pathological diagnosis of primary lung cancer (including small cell lung cancer).
3) Patients who have undergone lobectomy, segmentectomy (up to 4 segments, including subsegmentectomy), or partial resection.
4) Patients who have not been found to have a recurrence of the disease (or death from the disease).
1) Patients with a history of lung resection (including benign diseases).
2) Patients who have undergone preoperative treatment (drug therapy, radiation therapy, or chemoradiotherapy).
3) Patients who have undergone resection of more than one lobe (lobectomy + partial resection, lobectomy + segmentectomy, bi-lobectomy, pneumonectomy, etc.).
4) Patients who have undergone partial resection or segmentectomy of two or more separate parts of the lung.
5) Patients who have undergone bronchoplasty, vascularplasty, and combined resection of surrounding organs (chest wall, pericardium, etc.).
6) Patients who died within 30 days of surgery or died in hospital within 90 days of surgery.
7) Patients who refused to participate in the study.
8) Patients whom the investigator deems ineligible for any reason.
8000
| 1st name | Masayuki |
| Middle name | |
| Last name | Nakao |
Cancer Institute Hospital, Japanese Foundation for Cancer Research
Department of Thoracic Surgical Oncology
135-8550
Cancer Institute Hospital, 3-8-31 Ariake, Koto-ku, Tokyo, Japan
0335200111
masayuki.nakao@jfcr.or.jp
| 1st name | Masyauki |
| Middle name | |
| Last name | Nakao |
Cancer Institute Hospital, Japanese Foundation for Cancer Research
Department of Thoracic Surgical Oncology
135-0062
Cancer Institute Hospital, 3-8-31 Ariake, Koto-ku, Tokyo, Japan
0335200111
masayuki.nakao@jfcr.or.jp
Japanese Foundation for Cancer Research
The Japanese Association for Chest Surgery
Other
Japan
Cancer Institute Hospital, Japanese Foundation for Cancer Research
3-8-31 Ariake, Koto-ku, Tokyo, Japan
0335200111
med.shinsa@jfcr.or.jp
NO
がん研究会有明病院(東京都)
| 2024 | Year | 10 | Month | 07 | Day |
Unpublished
Enrolling by invitation
| 2024 | Year | 05 | Month | 01 | Day |
| 2024 | Year | 08 | Month | 22 | Day |
| 2024 | Year | 08 | Month | 22 | Day |
| 2026 | Year | 06 | Month | 30 | Day |
| 2026 | Year | 06 | Month | 30 | Day |
| 2027 | Year | 12 | Month | 31 | Day |
A Multicenter, Retrospective Study
| 2024 | Year | 10 | Month | 07 | Day |
| 2024 | Year | 10 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063639